Shopping Cart
Remove All
Your shopping cart is currently empty
PF-08046054 (SGN-PDL1V) is an antibody-drug conjugate (ADC) targeting PD-L1, created by linking an anti-PD-L1 antibody with the vedotin drug linker VcMMAE. This compound delivers MMAE intracellularly, exerting direct cytotoxic effects on PD-L1-expressing tumor cells. PF-08046054 is applicable for research in solid tumors.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Backorder | Backorder | |
| 5 mg | Inquiry | Backorder | Backorder |
| Description | PF-08046054 (SGN-PDL1V) is an antibody-drug conjugate (ADC) targeting PD-L1, created by linking an anti-PD-L1 antibody with the vedotin drug linker VcMMAE. This compound delivers MMAE intracellularly, exerting direct cytotoxic effects on PD-L1-expressing tumor cells. PF-08046054 is applicable for research in solid tumors. |
| Synonyms | SGN-PDL1V |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.